BE857218A - Nouveaux composes pharmaceutiquement actifs - Google Patents
Nouveaux composes pharmaceutiquement actifsInfo
- Publication number
- BE857218A BE857218A BE179687A BE179687A BE857218A BE 857218 A BE857218 A BE 857218A BE 179687 A BE179687 A BE 179687A BE 179687 A BE179687 A BE 179687A BE 857218 A BE857218 A BE 857218A
- Authority
- BE
- Belgium
- Prior art keywords
- active compounds
- pharmaceutically active
- new pharmaceutically
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3139176 | 1976-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE857218A true BE857218A (fr) | 1978-01-27 |
Family
ID=10322405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE179687A BE857218A (fr) | 1976-07-28 | 1977-07-27 | Nouveaux composes pharmaceutiquement actifs |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5315370A (xx) |
| AU (1) | AU2734677A (xx) |
| BE (1) | BE857218A (xx) |
| CA (1) | CA1070315A (xx) |
| DE (1) | DE2733953A1 (xx) |
| DK (1) | DK331877A (xx) |
| ES (1) | ES461100A2 (xx) |
| FI (1) | FI772293A (xx) |
| FR (1) | FR2359840A1 (xx) |
| IL (1) | IL52544A0 (xx) |
| LU (1) | LU77845A1 (xx) |
| NL (1) | NL7708375A (xx) |
| NO (1) | NO772668L (xx) |
| PL (1) | PL107847B1 (xx) |
| ZA (1) | ZA774552B (xx) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264614A (en) | 1978-11-16 | 1981-04-28 | Glaxo Group Limited | Amine derivatives |
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57102852A (en) * | 1980-12-19 | 1982-06-26 | Shionogi & Co Ltd | Dicarboxylic acid diamide |
-
1977
- 1977-07-18 IL IL52544A patent/IL52544A0/xx unknown
- 1977-07-22 DK DK331877A patent/DK331877A/da not_active Application Discontinuation
- 1977-07-26 AU AU27346/77A patent/AU2734677A/en active Pending
- 1977-07-26 LU LU77845A patent/LU77845A1/xx unknown
- 1977-07-27 DE DE19772733953 patent/DE2733953A1/de not_active Withdrawn
- 1977-07-27 ZA ZA00774552A patent/ZA774552B/xx unknown
- 1977-07-27 FR FR7723079A patent/FR2359840A1/fr not_active Withdrawn
- 1977-07-27 BE BE179687A patent/BE857218A/xx unknown
- 1977-07-27 FI FI772293A patent/FI772293A/fi not_active Application Discontinuation
- 1977-07-27 CA CA283,619A patent/CA1070315A/en not_active Expired
- 1977-07-27 NO NO772668A patent/NO772668L/no unknown
- 1977-07-28 JP JP9132477A patent/JPS5315370A/ja active Pending
- 1977-07-28 ES ES461100A patent/ES461100A2/es not_active Expired
- 1977-07-28 PL PL1977199908A patent/PL107847B1/pl unknown
- 1977-07-28 NL NL7708375A patent/NL7708375A/xx not_active Application Discontinuation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| US4264614A (en) | 1978-11-16 | 1981-04-28 | Glaxo Group Limited | Amine derivatives |
| WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA774552B (en) | 1978-06-28 |
| FI772293A (xx) | 1978-01-29 |
| AU2734677A (en) | 1979-02-01 |
| IL52544A0 (en) | 1977-10-31 |
| NO772668L (no) | 1978-01-31 |
| ES461100A2 (es) | 1978-12-01 |
| NL7708375A (nl) | 1978-01-31 |
| CA1070315A (en) | 1980-01-22 |
| FR2359840A1 (fr) | 1978-02-24 |
| PL199908A1 (pl) | 1978-11-20 |
| LU77845A1 (xx) | 1977-10-25 |
| JPS5315370A (en) | 1978-02-13 |
| DK331877A (da) | 1978-01-29 |
| PL107847B1 (pl) | 1980-03-31 |
| DE2733953A1 (de) | 1978-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA776129B (en) | Pharmaceutically active compounds | |
| BE854458A (fr) | Composes antihypertensifs | |
| BE852223A (fr) | Nouveaux aminoalcoylheterocycles | |
| SE437827B (sv) | Herbicidiskt aktiva foreningar | |
| DK206576A (da) | Farmakologisk aktive forbindelser | |
| MA18631A1 (fr) | Nouveaux composes azotes heterocycliques | |
| FR2346346A1 (fr) | Nouveaux amino-chromanols | |
| BE824923A (fr) | Nouveaux composes pharmaceutiquement actifs | |
| BE850941A (fr) | Nouveaux composes polypeptidiques | |
| FI773568A (fi) | Farmaceutiska preparat med laongtidsverkan | |
| SE7702771L (sv) | Farmakologiskt aktiva foreningar | |
| BE841001A (fr) | Nouveaux composes piperidino | |
| DK408577A (da) | Indgivelsessaet | |
| MC1156A1 (fr) | Composes cycliques | |
| BE857220R (fr) | Nouveaux composes pharmaceutiquement actifs | |
| BE857219R (fr) | Nouveaux composes pharmaceutiquement actifs | |
| BE850843A (fr) | Composes indolinospiropyrannes | |
| NO771884L (no) | Fremgangsm}te for fremstilling av terapeutisk aktive polyribonukleotider | |
| FI773812A (fi) | Farmaceutiska foereningar | |
| BE857218A (fr) | Nouveaux composes pharmaceutiquement actifs | |
| BE837950A (fr) | Nouveaux composes polycliques psychotropes | |
| BE861351A (fr) | Composes alcanoylanilides et leur preparation | |
| DK510977A (da) | Hygiejnisk-kosmetisk praeparat | |
| BE872492A (fr) | Nouveaux composes diazoiques | |
| FI773813A (fi) | Farmaceutiska foereningar |